NMTC
NeuroOne Medical Technologies Corporation
$0.94
+$0.01(+1.20%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$46.50M
Volume
1.21M
52W Range
$0.40 - $1.39
Target Price
$2.23
Order:
Income Statement
| Metric | Trend | Chart | 2014 Dec | 2015 Dec | 2016 Dec | 2017 Dec | 2019 Sep | 2020 Sep | 2021 Sep | 2022 Sep | 2023 Sep | 2024 Sep |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $773 | $742 | $-32.6K | -- | -- | -- | $178.1K | $171.2K | $2.0M | $3.5M | ||
| Total Revenue | $773 | $742 | -- | -- | -- | -- | $178.1K | $171.2K | $2.0M | $3.5M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $275.9K | $242.0K | $1.5M | $2.4M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $773 | $742 | $-32.6K | -- | -- | -- | $-97.7K | $-70.8K | $456.5K | $1.1M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-36.7K | $-30.9K | $-32.6K | $-3.1M | $-5.8M | $6.8M | $10.2M | $11.9M | $13.9M | $13.0M | ||
| Research & Development | -- | -- | -- | $735.3K | $1.5M | $2.1M | $3.9M | $4.9M | $6.9M | $5.1M | ||
| Research Expense | -- | -- | -- | $735.3K | $1.5M | $2.1M | $3.9M | $4.9M | $6.9M | $5.1M | ||
| Selling, General & Administrative | $36.7K | $30.9K | $32.6K | $2.3M | $4.3M | $4.8M | $6.3M | $7.2M | $6.9M | $7.9M | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | -- | -- | $338.8K | $242.0K | $1.1M | $173.4K | ||
| General & Administrative Expenses | $36.7K | $30.9K | $32.6K | $2.3M | $4.3M | $4.8M | $6.3M | $7.0M | $6.9M | $7.9M | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | -- | $338.8K | $270.6K | $173.4K | $173.4K | ||
| Salaries & Wages | -- | -- | -- | $-76.8K | $-491.7K | $-1.9M | $-64.8K | $-1.9M | $-1.5M | $1.3M | ||
| Depreciation & Amortization | -- | -- | -- | -- | $-6.3K | $25.3K | $58.4K | $96.3K | $1.5M | $224.5K | ||
| Depreciation & Amortization | -- | -- | -- | -- | $-6.3K | $25.3K | $275.9K | $96.3K | $1.5M | $224.5K | ||
| Amortization | -- | -- | -- | -- | $-21.2K | $177.5K | $134.2K | $111.9K | $1.5M | $67.3K | ||
| Other Operating Expenses | -- | -- | -- | -- | -- | -- | -- | -- | $-232.0K | $-52.1K | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-35.9K | $-30.9K | $-65.2K | $-3.1M | $-5.8M | $-4.9M | $-10.2M | $-10.0M | $-12.0M | $-11.9M | ||
| EBITDA | $-35.9K | $-30.9K | $-32.6K | $-3.5M | $-6.4M | $-6.1M | $-9.9M | $-9.9M | $-11.7M | $-12.0M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $330 | $14.0K | -- | $-35.5K | -- | $7.5M | $3.1K | -- | -- | -- | ||
| Intinc | $-330 | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-330 | $-14.0K | -- | $35.5K | -- | $-7.5M | $-3.1K | -- | -- | -- | ||
| Other Income/Expense | -- | $30.9K | -- | $350.9K | $553.4K | $2.0M | $-271.1K | $31.2K | $-95.8K | $201.9K | ||
| Other Special Charges | -- | -- | -- | $-350.9K | $-553.4K | $-2.0M | $271.1K | $31.2K | $95.8K | $-201.9K | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | -- | -- | -- | -- | -- | $-80.4K | $-663.6K | -- | $-74.5K | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-35.9K | $-30.9K | $-32.6K | $-4.9M | $-6.7M | $-6.1M | $-9.9M | $-10.0M | $-11.9M | $-12.3M | ||
| Pre-Tax Income | $-36.2K | $-30.9K | $-32.6K | $-4.8M | $-6.7M | $-2.0M | $-10.0M | $-10.0M | $-11.9M | $-12.3M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | -- | -- | -- | -- | -- | -- | $-271.1K | -- | -- | -- | ||
| NET INCOME | ||||||||||||
| Net Income | $-36.2K | $-61.8K | $-65.2K | $-5.1M | $-6.8M | $-13.6M | $-9.9M | $-10.0M | $-11.9M | $-12.3M | ||
| Net Income (Continuing Operations) | $-36.2K | $-61.8K | $-65.2K | $-5.1M | $-6.8M | $-13.6M | $-9.9M | $-10.0M | $-11.9M | $-12.3M | ||
| Net Income (Discontinued Operations) | $-36.2K | $-61.8K | $-65.2K | $-5.1M | $-6.8M | $-13.6M | $-9.9M | $-10.0M | $-11.9M | $-12.3M | ||
| Net Income (Common Stockholders) | $-36.2K | $-61.8K | $-65.2K | $-5.1M | $-6.8M | $-11.6M | $-9.9M | $-10.0M | $-11.9M | $-12.3M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-7.5M | -- | $-9.4M | $-12.1M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-36.7K | $-30.9K | $-32.6K | $-3.1M | $-5.8M | $6.8M | $10.5M | $10.2M | $15.4M | $15.3M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $1.7M | $1.7M | $5.1M | $6.6M | $4.0M | $5.4M | $10.7M | $16.0M | $18.1M | $26.8M | ||
| Average Shares Outstanding (Diluted) | $1.2M | $2.1M | -- | $6.6M | $4.0M | $5.4M | -- | $16.0M | $18.1M | $26.8M | ||
| Shares Outstanding | $2.6M | $2.6M | $50.0M | $7.9M | $4.6M | $7.7M | $16.2M | $50.0M | $24.0M | $50.0M | ||
| Basic EPS | -- | -- | -- | -- | -- | $-2.52 | $-0.93 | $-0.63 | $-0.65 | $-0.46 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-2.52 | $-0.93 | $-0.63 | $-0.65 | $-0.46 | ||
| Diluted EPS | $-0.03 | $-0.03 | -- | $-0.77 | $-1.71 | $-2.52 | $-0.93 | $-0.63 | $-0.65 | $-0.46 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | -- | -- | $-0.63 | $-0.65 | $-0.46 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | -- | -- | -- | $275.9K | -- | -- | -- | ||
| Development Expense | -- | -- | -- | -- | -- | -- | -- | $5.4M | -- | -- | ||
| Gain On Sale Of Business | -- | $-30.9K | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Net Income From Other Gains Losses | -- | -- | -- | $-240.1K | $-129.8K | $804.5K | $2.0K | -- | -- | -- | ||
| Net Operating Interest Income Expense | -- | -- | -- | $-1.4M | $-284.6K | -- | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | -- | $80.4K | $663.6K | -- | $74.5K | ||
| Other Gand A | $36.7K | $30.9K | $32.6K | $2.3M | $4.3M | $4.8M | $6.3M | $7.0M | $6.9M | $7.9M | ||
| Other Write Down | -- | -- | -- | -- | -- | -- | -- | $242.0K | -- | -- | ||
| Rent And Landing Fees | $36.7K | $30.9K | $32.6K | $2.3M | $4.3M | $103.2K | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMTC | $0.94 | +1.2% | 1.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NeuroOne Medical Technologies Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW